Could some breast cancer patients safely stop treatment early?
NCT ID NCT07407920
Summary
This study is testing whether patients with early-stage HER2-positive or triple-negative breast cancer can safely stop or reduce their medication after surgery. It focuses on patients whose cancer disappeared completely with pre-surgery treatment and who show no signs of leftover cancer in their blood. The goal is to see if these patients can maintain good outcomes with less treatment, potentially reducing side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANATOMIC STAGE I BREAST CANCER AJCC V8 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.